Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Roche Holding AG Basel American Depositary Shares (OP:RHHBY)

54.86 -0.36 (-0.65%)
Streaming Delayed Price Updated: 3:07 PM EDT, Sep 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 611,820
Open 54.55
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 55.22
Today's Range 54.43 - 55.20
52wk Range 39.50 - 60.85
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Revolution Medicines Got Its Breakthrough—What Moves It Next? ↗
FDA approved Revolution Medicines' RASONQUE for pancreatic cancer, but RVMD stock stayed flat as investors had priced in the news early, with rising expenses now in focus. 
Via MarketBeat
News headline image
Here's Why Ionis Pharmaceuticals' Steep Sell-off Was Overdone ↗
This biotech stock looks like a great candidate to buy on the admittedly steep dip. 
Via The Motley Fool

Performance

YTD
+6.6%
+6.6%
1 Month
-1.0%
-1.0%
3 Month
+6.4%
+6.4%
6 Month
+1.2%
+1.2%
1 Year
+30.5%
+30.5%

More News

Read More
News headline image
2 Stocks That Could Capitalize on the GLP-1 Boom ↗
Via The Motley Fool
News headline image
Genentech Announces Manufacturing Expansion in Hillsboro, Oregon
From Genentech
Via Business Wire
News headline image
Genentech Marks Topping out Milestone for New Holly Springs, North Carolina Manufacturing Facility
From Genentech
Via Business Wire
News headline image
2 GLP-1 Stocks That Could Double Your Money by 2031 ↗
Via The Motley Fool
News headline image
Vanguard Is Bullish on Developed Markets Outside the U.S. -- But How Can You Buy Them? These 2 ETFs Can Help. ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
FDA Grants Priority Review to Genentech’s Gazyva for Adults With Primary Membranous Nephropathy
From Genentech
Via Business Wire
News headline image
Should You Buy Eli Lilly Stock? Here's My Honest Take. ↗
Via The Motley Fool
News headline image
VYMI vs. VIGI: Which International Dividend ETF Is Better? ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
The Market Just Got Shaken—These 3 ETFs May Come Out Stronger ↗
Via MarketBeat
Topics Artificial Intelligence ETFs Stocks
News headline image
Genentech and Roche Present New Data in Alzheimer’s Disease From Across Its Integrated Pharmaceutical and Diagnostics Portfolio at AAIC
From Genentech
Via Business Wire
News headline image
IEFA vs. VXUS: Both Are Cheap. Both Are Broad. Here Is the Key Difference Long-Term Investors Need to Understand. ↗
Via The Motley Fool
Topics ETFs
News headline image
Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right. ↗
Via The Motley Fool
News headline image
Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer
From Genentech
Via Business Wire
News headline image
FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
From Genentech
Via Business Wire
News headline image
Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could ↗
Via The Motley Fool
News headline image
Jazz Pharmaceuticals' Lung Cancer Drug Setback in Late-Stage Trials: Here's Why the Stock Impact May Be More Limited Than It Looks ↗
Via The Motley Fool
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials
Via Investor Brand Network
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
Via Investor Brand Network
News headline image
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
From BioMedWire
Via GlobeNewswire
News headline image
Teva Just Delivered More Good News on Its Biggest Growth Driver. Is the Stock Still a Bargain? ↗
Via The Motley Fool
News headline image
FDA Accepts Supplemental Biologics License Application for Genentech’s Lunsumio and Polivy Combination for People With Relapsed or Refractory Large B-Cell Lymphoma
From Genentech
Via Business Wire
News headline image
FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer
From Genentech
Via Business Wire
News headline image
IXUS vs. IEFA: Which International ETF Is Better for Most Investors? ↗
Via The Motley Fool
Topics ETFs

Frequently Asked Questions

Is Roche Holding AG Basel American Depositary Shares publicly traded?
Yes, Roche Holding AG Basel American Depositary Shares is publicly traded.
What exchange does Roche Holding AG Basel American Depositary Shares trade on?
Roche Holding AG Basel American Depositary Shares trades on the OTC Traded
What is the ticker symbol for Roche Holding AG Basel American Depositary Shares?
The ticker symbol for Roche Holding AG Basel American Depositary Shares is RHHBY on the OTC Traded
What is the current price of Roche Holding AG Basel American Depositary Shares?
The current price of Roche Holding AG Basel American Depositary Shares is 54.86
When was Roche Holding AG Basel American Depositary Shares last traded?
The last trade of Roche Holding AG Basel American Depositary Shares was at 09/04/26 03:07 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.